173 related articles for article (PubMed ID: 14587962)
1. Treating patients with acute gastrointestinal bleeding or rebleeding.
Pisegna JR
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):81S-86S. PubMed ID: 14587962
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
3. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
Cheer SM; Prakash A; Faulds D; Lamb HM
Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
[TBL] [Abstract][Full Text] [Related]
4. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Ramdani A; Mignon M; Samoyeau R
Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
[TBL] [Abstract][Full Text] [Related]
5. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
6. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Enns R; Andrews CN; Fishman M; Hahn M; Atkinson K; Kwan P; Levy A
Can J Gastroenterol; 2004 Sep; 18(9):567-71. PubMed ID: 15457296
[TBL] [Abstract][Full Text] [Related]
7. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
8. Intravenous pantoprazole: a new tool for acutely ill patients who require acid suppression.
Trépanier EF
Can J Gastroenterol; 2000 Nov; 14 Suppl D():11D-20D. PubMed ID: 11110607
[TBL] [Abstract][Full Text] [Related]
9. Pantoprazole, Prout and the proton pump.
Playford RJ; Podas T; Modlin I
Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
[TBL] [Abstract][Full Text] [Related]
10. The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome.
Tang SJ; Nieto JM; Jensen DM; Ohning GV; Pisegna JR
J Clin Gastroenterol; 2002 Jan; 34(1):62-3. PubMed ID: 11743248
[TBL] [Abstract][Full Text] [Related]
11. The changing role of H2-receptor antagonists in acid-related diseases.
Lamers CB
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
[TBL] [Abstract][Full Text] [Related]
12. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Lew EA; Pisegna JR; Starr JA; Soffer EF; Forsmark C; Modlin IM; Walsh JH; Beg M; Bochenek W; Metz DC
Gastroenterology; 2000 Apr; 118(4):696-704. PubMed ID: 10734021
[TBL] [Abstract][Full Text] [Related]
13. Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome.
Désir B; Poitras P
Can J Gastroenterol; 2001 Dec; 15(12):795-8. PubMed ID: 11773945
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic options in the management of nonvariceal upper gastrointestinal bleeding.
Pais SA; Yang R
Curr Gastroenterol Rep; 2003 Dec; 5(6):476-81. PubMed ID: 14602055
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Jensen DM; Pace SC; Soffer E; Comer GM;
Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
[TBL] [Abstract][Full Text] [Related]
16. Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions.
Metz DC; Comer GM; Soffer E; Forsmark CE; Cryer B; Chey W; Pisegna JR
Aliment Pharmacol Ther; 2006 Feb; 23(3):437-44. PubMed ID: 16423003
[TBL] [Abstract][Full Text] [Related]
17. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
Martin RA
Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
[TBL] [Abstract][Full Text] [Related]
18. Intravenous proton pump inhibitors in the critical care setting.
Morgan D
Crit Care Med; 2002 Jun; 30(6 Suppl):S369-72. PubMed ID: 12072664
[TBL] [Abstract][Full Text] [Related]
19. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
20. History of acid suppression: focus on the hospital setting.
Garnett WR
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):56S-60S. PubMed ID: 14587958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
